During SOHO 2019 in Houston, US, the Lymphoma Hub was pleased to talk with Dr Kieron M. Dunleavy from The George Washington University, Washington, US, about the treatment of double-hit lymphoma. He discusses treatment strategies aimed at patients with MYC and BCL2/BCL6 rearrangements, including BCL2 inhibitors, CAR T-cells, and bispecific antibodies.
The European Lymphoma Institute is comprised of a network of top European specialists in the field of lymphoma who are dedicated to research, training and education. Together they look to define strategies to analyse and characterize lymphoma and its common diagnostic procedures and therapeutic standards, as well as to facilitate clinical and fundamental research. This all results in the advancement of lymphoma research and it guarantees equal access for all patients to the best possible care.